Mitsubishi UFJ Asset Management Co. Ltd. Raises Stock Holdings in Agilent Technologies, Inc. $A

Mitsubishi UFJ Asset Management Co. Ltd. lifted its holdings in Agilent Technologies, Inc. (NYSE:A) by 4.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 599,581 shares of the medical research company’s stock after buying an additional 24,687 shares during the quarter. Mitsubishi UFJ Asset Management Co. Ltd. owned approximately 0.21% of Agilent Technologies worth $82,712,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of A. Brighton Jones LLC grew its stake in Agilent Technologies by 6.1% in the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock worth $626,000 after purchasing an additional 270 shares in the last quarter. Jones Financial Companies Lllp grew its stake in Agilent Technologies by 15.9% in the first quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock worth $602,000 after purchasing an additional 769 shares in the last quarter. Geneos Wealth Management Inc. grew its stake in Agilent Technologies by 54.8% in the first quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock worth $70,000 after purchasing an additional 212 shares in the last quarter. Acadian Asset Management LLC grew its stake in Agilent Technologies by 16.5% in the first quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock worth $625,000 after purchasing an additional 758 shares in the last quarter. Finally, Sivia Capital Partners LLC bought a new position in Agilent Technologies in the second quarter worth approximately $273,000.

Agilent Technologies Stock Up 0.7%

Shares of NYSE A opened at $118.49 on Friday. The company has a current ratio of 2.07, a quick ratio of 1.59 and a debt-to-equity ratio of 0.44. The stock has a market capitalization of $33.49 billion, a PE ratio of 26.16, a price-to-earnings-growth ratio of 2.48 and a beta of 1.22. The stock’s fifty day simple moving average is $115.99 and its two-hundred day simple moving average is $131.97. Agilent Technologies, Inc. has a 12-month low of $106.55 and a 12-month high of $160.27.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, February 25th. The medical research company reported $1.36 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.37 by ($0.01). The company had revenue of $1.80 billion for the quarter, compared to the consensus estimate of $1.81 billion. Agilent Technologies had a net margin of 18.26% and a return on equity of 24.49%. The firm’s revenue was up 7.0% compared to the same quarter last year. During the same period last year, the business posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 5.900-6.040 EPS and its Q2 2026 guidance at 1.390-1.420 EPS. As a group, analysts expect that Agilent Technologies, Inc. will post 5.95 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, April 22nd. Stockholders of record on Tuesday, March 31st were given a $0.255 dividend. The ex-dividend date of this dividend was Tuesday, March 31st. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.9%. Agilent Technologies’s dividend payout ratio (DPR) is presently 22.52%.

Analysts Set New Price Targets

A has been the topic of several research analyst reports. TD Cowen dropped their price objective on Agilent Technologies from $170.00 to $157.00 and set a “buy” rating on the stock in a research note on Thursday, February 26th. Wells Fargo & Company dropped their price objective on Agilent Technologies from $175.00 to $165.00 and set an “overweight” rating on the stock in a research note on Thursday, February 26th. Morgan Stanley dropped their price objective on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating on the stock in a research note on Tuesday, March 3rd. Barclays dropped their price objective on Agilent Technologies from $150.00 to $140.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 14th. Finally, UBS Group dropped their price objective on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a research note on Thursday, February 26th. Two investment analysts have rated the stock with a Strong Buy rating, eleven have issued a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, Agilent Technologies has a consensus rating of “Buy” and a consensus price target of $163.71.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett?Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.